| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.32 | 0.04 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |